Gilead Sciences, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
GILD Nasdaq 2836 www.gilead.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Gilead Sciences, Inc.

Evaluating Gilead Sciences (GILD) Valuation After Q1 Beat Guidance Shift And New HIV Priority Review - May 16th, 2026 1:08 pm
Tango Therapeutics (TNGX) Is Down 10.7% After Pipeline Pivot And Board Changes - Has The Bull Case Changed? - May 16th, 2026 8:10 am
Tomato Prices Aren’t the Only Problem. How Retirees Can Beat Inflation. - May 15th, 2026 4:21 pm
Gilead Prices $3 Billion of Senior Unsecured Notes - May 14th, 2026 7:21 pm
Assembly Biosciences Touts HSV, Hepatitis D Catalysts at BofA Conference - May 14th, 2026 5:05 am
Veeva Commercial Summit to Feature Biopharma's AI Successes and the Path to Agentic Commercial - May 14th, 2026 5:03 am
TIME Names California Water Service Group One of the World’s Most Impactful Companies - May 13th, 2026 2:15 pm
Is It Worth Investing in Gilead (GILD) Based on Wall Street's Bullish Views? - May 13th, 2026 7:30 am
Gilead to Present New Data Advancing Care in PBC and Viral Hepatitis at EASL 2026 - May 13th, 2026 6:30 am
Trinity's TGaS Advisors Announces Winners of 9th Annual Best of Benchmark Awards - May 12th, 2026 6:00 am
GILD Q1 Deep Dive: HIV Growth, Oncology Pipeline, and Margin Management Shape 2026 Outlook - May 11th, 2026 6:36 pm
Gilead Sciences, Inc. (GILD) Outlook Cut Sharply on $11.5B IPR&D and Financing Costs - May 11th, 2026 2:01 pm
Gilead Sciences, Inc. (NASDAQ:GILD) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - May 11th, 2026 6:17 am
Stronger HIV Pipeline And Acquisition Charges Might Change The Case For Investing In Gilead Sciences (GILD) - May 9th, 2026 8:19 am
Gilead Slips As Descovy Steals The 'Spotlight' From Big Yeztugo Expectations - May 8th, 2026 2:07 pm
Gilead posts positive Q1 buoyed by HIV drug growth - May 8th, 2026 10:59 am
Gilead Sciences' Increased Yeztugo Guidance is 'Good Enough' for the Stock, Morgan Stanley Says - May 8th, 2026 9:47 am
Gilead (GILD) Q1 2026 Earnings Call Transcript - May 8th, 2026 7:09 am
Gilead Stock Falls After Earnings. A Big Acquisition Spree Is Coming at a Cost. - May 8th, 2026 2:10 am
Gilead Sciences Q1 Earnings Call Highlights - May 7th, 2026 8:13 pm